October 8, 2016
Research and Development
Clinical trials: what are we not being told?
Transparency International launches new principles to promote integrity in the pharmaceutical industry in Latin America
Clinical Trial Transparency
Business Principles for Promoting Integrity in the Pharmaceutical Sector in Latin America
Corruption in the pharmaceutical sector
Rodwin, M.A. (2013) ‘Five un-easy pieces of pharmaceutical policy reform’, The Journal of Law, Medicine & Ethics, 41(3), pp. 581–589.
Rodwin, M.A. & Abramson, J.D. (2012) ‘Clinical trial data as a public good’, JAMA, 308(9), p. 871.
Durisch, P., den Boer, A., Schipper, I., & Kohli, A. (2016) Industry-sponsored clinical drug trials in Egypt: Ethical questions in a challenging context. Raphaël de Riedmatten.
Light, D.W., Lexchin, J. & Darrow, J.J. (2013) ‘Institutional corruption of pharmaceuticals and the myth of safe and effective drugs’, The Journal of Law, Medicine & Ethics, 41(3), pp. 590–600.